ARCHIVES

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

NCI Says Sponsored Meetings Must Be Held In Smoke-Free Localities As of Jan. 1.

July 21, 2006

NCI Would Fund 152 More Grants Under President’s Budget

February 17, 1995

NCI Intramural Research: More Than 200 Scientists At Frederick To Become NCI Employees This Year

March 26, 1999